PET Imaging of Integrin αVβ3 Expression
Authors:
Open Access
- 1 January 2011
- journal article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 1, 48-57
Abstract
PET imaging of integrin αvβ3 expression has been studied intensely by the academia and recently also by the industry. Imaging of integrin αvβ3 expression is of great potential value, as the integrin αvβ3 is a key player in tumor metastasis and angiogenesis. Therefore PET imaging of this target might be a suitable in-vivo biomarker of angiogenesis and metastatic potential of tumors. In this manuscript, the various strategies for PET imaging of the integrin αvβ3 will be summarized, including monomeric and multimeric radiolabelled RGD peptides and nanoparticles. While most experiments have been performed using preclinical tumor models, more and more clinical results on PET imaging of αvβ3 expression are available and will be discussed in detail. However, while a multitude of radiotracer strategies have been successfully evaluated for PET imaging of αvβ3, the ultimate clinical value of this new imaging biomarker still has to be evaluated in large clinical trials.Keywords
This publication has 54 references indexed in Scilit:
- 64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor v 3 Integrin ExpressionJournal of Nuclear Medicine, 2007
- Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.2006
- Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.2006
- microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.2005
- Chemically Functionalized Carbon NanotubesSmall, 2004
- MicroPET imaging of breast cancer ?-integrin expression with Cu-labeled dimeric RGD peptidesMolecular Imaging and Biology, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Multimeric Cyclic RGD Peptides as Potential Tools for Tumor Targeting: Solid‐Phase Peptide Synthesis and Chemoselective Oxime LigationChemistry – A European Journal, 2003
- Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.1999
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995